Search research articles
Contact Us
Filters
Showing results (221-230 of 382) with videos related to
Page
of 39
Sort By:
American Journal of Clinical Pathology
|
February 10, 2018
Giant Cell Tumor of Bone in Patients 55 Years and Older: A Study of 34 Patients
Cory J Broehm, Carrie Y Inwards, Alyaa Al-Ibraheemi, et al.
Bone Marrow Transplantation
|
November 2, 2004
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate
M A Gertz, M Q Lacy, A Dispenzieri, et al.
Leukemia & Lymphoma
|
July 7, 2007
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone
Lijo Simpson, Stephen M Ansell, Joseph P Colgan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 21, 2020
Outcomes of Autologous Stem Cell Transplant Consolidation in Primary Central Nervous System Lymphoma: A Mayo Clinic Experience
Arushi Khurana, Ivana N Micallef, Betsy R LaPlant, et al.
The American Journal of Surgical Pathology
|
August 16, 2016
Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 Patients
Alyaa Al-Ibraheemi, Carrie Y Inwards, Riyam T Zreik, et al.
Leukemia & Lymphoma
|
September 27, 2019
Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?
Mattia Novo, Grzegorz S Nowakowski, Thomas M Habermann, et al.
Cancer
|
June 11, 2008
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group
Stephen M Ansell, David J Inwards, Kendrith M Rowland, et al.
Blood Cancer Journal
|
January 8, 2021
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma
Alessia Castellino, Aung M Tun, Yucai Wang, et al.
The American Journal of Surgical Pathology
|
May 16, 2020
Giant Cell Tumor of Bone With Cartilage Matrix: A Clinicopathologic Study of 17 Cases
Iva Brčić, Feisal Yamani, Carrie Y Inwards, et al.
Bone Marrow Transplantation
|
March 9, 2010
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies
S G Holtan, W J Hogan, M A Elliott, et al.
Page
of 39
Search research articles
Search
Showing results (221-230 of 382) with videos related to
Sort By:
Page
of 39
American Journal of Clinical Pathology
|
February 10, 2018
Giant Cell Tumor of Bone in Patients 55 Years and Older: A Study of 34 Patients
Cory J Broehm, Carrie Y Inwards, Alyaa Al-Ibraheemi, et al.
Bone Marrow Transplantation
|
November 2, 2004
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate
M A Gertz, M Q Lacy, A Dispenzieri, et al.
Leukemia & Lymphoma
|
July 7, 2007
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone
Lijo Simpson, Stephen M Ansell, Joseph P Colgan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 21, 2020
Outcomes of Autologous Stem Cell Transplant Consolidation in Primary Central Nervous System Lymphoma: A Mayo Clinic Experience
Arushi Khurana, Ivana N Micallef, Betsy R LaPlant, et al.
The American Journal of Surgical Pathology
|
August 16, 2016
Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 Patients
Alyaa Al-Ibraheemi, Carrie Y Inwards, Riyam T Zreik, et al.
Leukemia & Lymphoma
|
September 27, 2019
Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?
Mattia Novo, Grzegorz S Nowakowski, Thomas M Habermann, et al.
Cancer
|
June 11, 2008
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group
Stephen M Ansell, David J Inwards, Kendrith M Rowland, et al.
Blood Cancer Journal
|
January 8, 2021
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma
Alessia Castellino, Aung M Tun, Yucai Wang, et al.
The American Journal of Surgical Pathology
|
May 16, 2020
Giant Cell Tumor of Bone With Cartilage Matrix: A Clinicopathologic Study of 17 Cases
Iva Brčić, Feisal Yamani, Carrie Y Inwards, et al.
Bone Marrow Transplantation
|
March 9, 2010
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies
S G Holtan, W J Hogan, M A Elliott, et al.
Page
of 39